Argon Medical announces acquisition of Accurate Medical Therapeutics microcatheters

Feb 07,2025


Argon Medical has announced the acquisition of Accurate Medical Therapeutics’ SeQure and DraKon microcatheters.

 

 

Microcatheters such as SeQure and DraKon are commonly used by physicians to conduct interventional procedures in which therapeutic agents or devices are introduced into the small vessels delivering blood to a tumour or abnormality. As such, physicians often select a microcatheter for a procedure based on the catheter’s ability to navigate to the target and its compatibility with therapeutic agents or devices.

 

Both the SeQure and Drakon catheters earned a strong reputation for being easy to navigate and broadly compatible, a recent press release states. Further, the company shares that SeQure is the only reflux control microcatheter designed to create a fluid barrier that directs the flow of therapeutic agents and devices toward the intended target.

 

“A microcatheter can make or break a procedure,” said Neal Khurana, interventional radiologist and co-founder of EmboPartners, a physician-run organisation that specialises in minimally invasive vascular embolization procedures for improved patient care. “A well-designed microcatheter determines whether you achieve precise navigation, efficient delivery of embolic materials, and ultimately, optimal patient outcomes. The DraKon and SeQure microcatheters have become preferred tools in my practice due to their dependable trackability through tortuous vessels, the performance of their hydrophilic coating, and their ability to deliver contrast and embolics efficiently, even through the smallest catheter sizes.”

 

“Adding the SeQure and DraKon microcatheters to our existing product portfolio marks an important first step in expanding the products we offer interventional oncologists beyond diagnostic procedures and into therapeutic delivery,” said George Leondis, president and chief executive officer,  Argon Medical. “As we do so, we also expand the ways in which we can improve the lives of patients and caregivers through the delivery of best-in-class medical devices and superior service, in alignment with our company mission.”

Related News

Content refinement in progress.

视频标题